JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

COVID-19-sensitive tumour response: 2-year assessment of the SARS-CoV-2 humoral response in cancer patients in oncology hospital in Poland

  • 0Department of Emergency, Maria Sklodowska-Curie Bialystok Oncology Centre, Białystok, Poland. pkosiorek@onkologia.bialystok.pl.
Cancer Immunology, Immunotherapy : Cii +

|

December 21, 2024

|

December 21, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Cancer patients exhibit a stronger natural immune response to viral infections like SARS-CoV-2, even without vaccination or therapy. This natural defense influences infection outcomes and remains a key area for further research in oncology and virology.

Area Of Science

  • Oncology
  • Immunology
  • Virology

Background

  • Vaccination is critical for viral infection defense, including SARS-CoV-2.
  • Cancer patients' humoral response to SARS-CoV-2 is influenced by cancer itself, beyond therapy and vaccination.
  • A robust natural defense against viral pathogens is observed in some cancer patients, potentially explaining asymptomatic SARS-CoV-2 infections.

Purpose Of The Study

  • To investigate the impact of the cancer process on the humoral immune response in oncological patients.
  • To compare antibody responses in vaccinated cancer patients versus those who recovered from COVID-19.
  • To understand the interplay between cancer, anticancer therapies, and antiviral immunity.

Main Methods

  • Observation of 1,668 individuals over 2 years.
  • Analysis of 5,082 SARS-CoV-2 IgG and IgM antibody samples.
  • Assessment of antibody concentrations in different groups of cancer patients (undergoing therapy, post-COVID-19, vaccinated).

Main Results

  • Oncological patients without vaccination or anticancer therapy demonstrated a significantly stronger natural humoral response.
  • This enhanced response was observed across various cancer types including breast, lung, colon, kidney, and testicular cancer.
  • The magnitude of the response varied considerably based on the specific cancer type.

Conclusions

  • The cancer process itself can potentiate a natural humoral immune response against viral infections.
  • Further research is needed to determine if SARS-CoV-2 infection compromises the natural anticancer immune response.
  • Understanding these interactions is crucial for managing viral infections in cancer patients.

Keywords: